Endocrine-responsive breast cancer and strategies for combating resistance

被引：704

作者：

Ali, S

Coombes, RC

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Dept Canc Med, London W12 0NN, England

[2] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Canc Res Campaign Labs, London W12 0NN, England

来源：

NATURE REVIEWS CANCER | 2002年 / 2卷 / 02期

关键词：

D O I：

10.1038/nrc721

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Deaths from breast cancer have fallen markedly over the past decade due, in part, to the use of endocrine agents that reduce the levels of circulating oestrogens or compete with oestrogen for binding to its receptor. However, many breast tumours either fail to respond or become resistant to endocrine therapies. By understanding the mechanisms that underlie this resistance, we might be able to develop strategies for overcoming or bypassing it.

引用

收藏

页码：101 / +

页数：13

相关论文

共 159 条

[71] ATP-dependent remodeling and acetylation as regulators of chromatin fluidity [J].

Kingston, RE ;

Narlikar, GJ .

GENES & DEVELOPMENT, 1999, 13 (18) :2339-2352

[72] Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: A meta-analysis of four randomized trials [J].

Klijn, JGM ;

Blamey, RW ;

Boccardo, F ;

Tominaga, T ;

Duchateau, L ;

Sylvester, R .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :343-353

[73] Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities [J].

Koh, SS ;

Chen, DG ;

Lee, YH ;

Stallcup, MR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (02) :1089-1098

[74] Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity [J].

Kousteni, S ;

Bellido, T ;

Plotkin, LI ;

O'Brien, CA ;

Bodenner, DL ;

Han, L ;

Han, K ;

DiGregorio, GB ;

Katzenellenbogen, JA ;

Katzenellenbogen, BS ;

Roberson, PK ;

Weinstein, RS ;

Jilka, RL ;

Manolagas, SC .

CELL, 2001, 104 (05) :719-730

[75] Cloning of a novel estrogen receptor expressed in rat prostate and ovary [J].

Kuiper, GGJM ;

Enmark, E ;

PeltoHuikko, M ;

Nilsson, S ;

Gustafsson, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :5925-5930

[76]

Kurokawa H, 2000, CANCER RES, V60, P5887

[77] Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy [J].

Kuukasjarvi, T ;

Kononen, J ;

Helin, H ;

Holli, K ;

Isola, J .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2584-2589

[78]

LACASSAGNE A., 1936, AMER JOUR CANCER, V27, P217

[79]

Lakhani SR, 1999, J PATHOL, V187, P272, DOI 10.1002/(SICI)1096-9896(199902)187:3<272::AID-PATH265>3.0.CO

[80]

2-2

← 3 4 5 6 7 8 9 10 11 12 →